CNVIF
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.03 | $93,459 | -$5M |
| 2025 Q1 | -0.03 | $158,747 | -$3M |
| 2025 Q4 | -0.07 | $263,131 | -$3M |
| 2025 Q3 | -0.04 | $46,240 | -$4M |
| 2025 Q2 | -0.05 | $40,727 | -$3M |
| 2024 Q1 | -0.13 | $6M | -$9M |
| 2024 Q4 | -0.04 | $0 | -$5M |
| 2024 Q2 | -0.01 | $0 | -$2M |